Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Berek

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Journal of Neurology|December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosisManuel Comabella, Harald Hegen, Luisa M Villar, et al.
The Lancet. Neurology|December 2, 2014
Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational studyJohann Willeit, Theresa Geley, Johannes Schöch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis and Related Disorders|July 7, 2020
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysisAhmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Journal of Neurology|December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosisManuel Comabella, Harald Hegen, Luisa M Villar, et al.
The Lancet. Neurology|December 2, 2014
Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational studyJohann Willeit, Theresa Geley, Johannes Schöch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis and Related Disorders|July 7, 2020
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysisAhmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.
Pageof 10